Burn Injury and Pulmonary Sepsis: Development of a Clinically Relevant Model

Journal of Trauma - Injury, Infection and Critical Care

Volumn 56, Issue 2, 2004, Pages 272-278

  Davis, Kimberly A ^a   Santaniello, John M ^a   He, Li Ke ^a   Muthu, Kuzhali ^a   Sen, Soman ^a   Jones, Stephen B ^a   Gamelli, Richard L ^a   Shankar, Ravi ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alveolar macrophage; Bronchoalveolar lavage (BAL); Burn; Cytokine; Pneumonia; Sepsis; Thermal injury

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BONE MARROW CELL; BURN; CLONOGENESIS; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE MODEL; EXPERIMENTAL INFECTION; FULL THICKNESS BURN; GRAM STAINING; HEMATOPOIESIS; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; LUNG LAVAGE; LUNG SEPSIS; MALE; MONOCYTE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESUSCITATION; SCALD; SEPSIS;

EID: 1542346824     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000108995.64133.90     Document Type: Article

References (31)

1. Deitch EA, Goodman ER. Prevention of multiple organ failure. Surg Clin North Am. 1999;79:1471-1488.
2. Bulger EM, Jurkovich GJ, Gentilello LM, Maier RV. Current clinical options for the treatment and management of acute respiratory distress syndrome. J Trauma. 2000;48:562-572.
3. Bernard GR, Artugas A, Brigham KL, et al. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med. 1994;20:225-232.
4. Rinaldo JE. Mechanisms and mediators of the adult respiratory distress syndrome. Clin Chest Med. 1990;11:621-632.
5. Hashimoto S, Pittet JF, Hong K, et al. Depletion of alveolar macrophages decrease neutrophil chemotaxis to Pseudomonas airspace infections. Am J Physiol. 1996;270(5 pt 1):L819-L828.
6. Broug-Holub E, Toews GB, van Iwaarden JF, et al. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect Immun. 1997;65:1139-1146.
7. Davis KA, Fabian TC, Ragsdale DN, Trenthem LL, Croce MA, Proctor KG. G-CSF and neutrophil-related changes in local host defense during recovery from shock and intra-abdominal sepsis. Surgery. 1999;126:305-313.
8. Davis KA, Fabian TC, Ragsdale DN, Trenthem LL, Croce MA, Proctor KG. Combination therapy that targets secondary pulmonary changes after abdominal trauma. Shock. 2001;15:479-484.
9. Ayala A, Chung CS, Lomas JL, et al. Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects ot TLR-4 and TLR-4/ FasL deficiency. Am J Pathol. 2002;161:2283-2294.
10. Khadaroo RG, Lu Z, Powers KA, Papia G, Kapus A, Rotstein OD. Impaired activation of mitogen-activated protein kinases after hemorrhagic shock. Surgery. 2002;132:360-364.
11. Shoup M, Weisenberger JM, Wang JL, Pyle JM, Gamelli RL, Shankar R. Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann Surg. 1998;228:112-122.
12. Santangelo S, Gamelli RL, Shankar R. Myeloid commitment shifts toward monocytopoiesis after thermal injury and sepsis. Ann Surg. 2001;233:97-106.
13. Walker HL, Mason AD. A standard animal burn. J Trauma. 1968;8:1049-1051.
14. Cooper S, Broxmeyer HE. Colongenic methods in vitro for the enumeration of granulocyte-macrophage progenitor cells (CFU-GM) in human bone marrow and mouse bone marrow and spleen. J Tissue Cult Methods. 1991;13:77-82.
15. Havell EA. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol. 1989;143:2894-2899.
16. Kelly J. Cytokines of the lung. Am Rev Respir Dis. 1990;141:765-788.
17. Windsor ACJ, Walsh CJ, Mullen PG, et al. Tumor necrosis factor-a blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis with inhibition of neutrophil oxygen radical generation. J Clin Invest. 1993;91:1459-1468.
18. Mulligan MS, Vaporciyan AA, Miyasaka M, Tamatani T, Ward PA. Tumor necrosis factor regulates in vivo intrapulmonary expression of ICAM-1. Am J Physiol. 1993;142:1739-1744.
19. Ming WJ, Bersani L, Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol. 1987;138:1469-1474.
20. Meduri GM, Headley S, Kohler G, et al. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995;107:1062-1073.
21. Kooguchi K, Hashimoto S, Kobayashi A, et al. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect Immun. 1998;66:3164-3169.
22. Schinkel C, Sendtner R, Zimmer S, Faist E. Functional analysis of monocyte subsets in surgical sepsis. J Trauma. 1998;44:743-749.
23. Rainer TH, Chan TY, Cocks RA. Do peripheral blood counts have any prognostic value following trauma? Injury. 1999;30:179-185.
24. Millar AB, Foley NM, Singer M, et al. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet. 1989;2:712-714.
25. Hyers M, Tricomi SM, Dettenmeier PA, et al. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am Rev Respir Dis. 1991;144:268-271.
26. Agouridakis P, Kyriakou D, Alexandrakis MG, et al. The predictive role of serum and bronchoalveolar lavage cytokines and adhesion molecules for acute respiratory distress syndrome development and outcome. Respir Res. 2002;3:25-34.
27. Meduri GM, Kohler F, Headley S, et al. Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome. Chest. 1995;108:1303-1314.
28. Martin TR. Lung cytokines and ARDS. Chest. 1999;116(1 suppl):2S-8S.
29. Martin TR, Ruzinski JT, Steinberg KP, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome (ARDS) [abstract]. Am J Respir Crit Care Med. 1998;157:A679.
30. Davis KA, Fabian TC, Croce MA, Proctor KG. Prostanoids: early mediators in the secondary injury that develops after unilateral pulmonary contusion. J Trauma. 1999;46:824-832.
31. Santangelo S, Shoup M, Gamelli RL, Shankar R. Prostaglandin E2 receptor antagonist (SC-19220) treatment restores the balance to bone marrow myelopoiesis after bum sepsis. J Trauma. 2000;48:826-831.